Trial Profile
A study comparing efficacy between dapagliflozin and canagliflozin in long standing type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Oct 2018
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary) ; Dapagliflozin (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 18 Oct 2018 New trial record
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes